What is the official price of enzalutamide?

Enzalutamide (Enzalutamide) is an oral antiandrogen used to treat advanced prostate cancer. As a targeted therapy, enzalutamide exerts anti-tumor effects by inhibiting the activity of androgen receptors.

Enzalutamide (enzalutamide) is now on the market in China and is included in the scope of medical insurance. Patients can easily purchase it domestically, with the price remaining in the range of RMB 4,000 to RMB 5,000. For detailed policies on specific costs and medical insurance reimbursement, it is recommended to consult the pharmacy of your local hospital to obtain the most accurate information.

As for foreign countries, generic drugs are mainly more affordable, especially Indian generic drugs, which are the most economical and affordable. The price is about more than 2,000 yuan, which is only about half of the domestic price. It is worth mentioning that the ingredients of these generic drugs are basically the same as those of the original drugs.

Enzalutamide's main mechanism of action is to inhibit the growth and spread of prostate cancer cells by inhibiting the androgen receptor (Androgen Receptor, AR). In prostate cancer, the androgen receptor is a key promoter that drives prostate cancer cells to grow and spread. Enzalutamide (Enzalutamide) binds with the androgen receptor, preventing the binding of androgens and inhibiting their activity, thereby inhibiting the growth and spread of prostate cancer cells.

Enzalutamide is commonly used to treat advanced prostate cancer, including metastatic and non-metastatic prostate cancer. It can be used as a first-line treatment option or as a subsequent treatment option, especially in patients who have already received hormone therapy or who have failed to respond to hormone therapy.

Enzalutamide (enzalutamide) is usually taken by mouth once daily at a dose of 160 mg per dose. Patients should use the medicine correctly under the guidance of a doctor and strictly follow the doctor's instructions. During the use of enzalutamide (enzalutamide) , patients need to be reviewed regularly to monitor the efficacy and adverse reactions so that the treatment plan can be adjusted in a timely manner.